Literature DB >> 34715007

The Many Roles of Cholesterol in Sepsis: A Review.

Daniel A Hofmaenner1, Anna Kleyman1, Adrian Press2, Michael Bauer2, Mervyn Singer1.   

Abstract

The biological functions of cholesterol are diverse, ranging from cell membrane integrity, cell membrane signaling, and immunity to the synthesis of steroid and sex hormones, vitamin D, bile acids, and oxysterols. Multiple studies have demonstrated hypocholesterolemia in sepsis, the degree of which is an excellent prognosticator of poor outcomes. However, the clinical significance of hypocholesterolemia has been largely unrecognized. We undertook a detailed review of the biological roles of cholesterol, the impact of sepsis, its reliability as a prognosticator in sepsis, and the potential utility of cholesterol as a treatment. Sepsis affects cholesterol synthesis, transport, and metabolism. This likely impacts its biological functions, including immunity, hormone and vitamin production, and cell membrane receptor sensitivity. Early preclinical studies show promise for cholesterol as a pleiotropic therapeutic agent. Hypocholesterolemia is a frequent condition in sepsis and an important early prognosticator. Low plasma concentrations are associated with wider changes in cholesterol metabolism and its functional roles, and these appear to play a significant role in sepsis pathophysiology. The therapeutic impact of cholesterol elevation warrants further investigation.

Entities:  

Keywords:  cholesterol; hypocholesterolemia; lipid metabolism; sepsis

Mesh:

Substances:

Year:  2022        PMID: 34715007      PMCID: PMC8886946          DOI: 10.1164/rccm.202105-1197TR

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   30.528


  97 in total

1.  Statins inhibit NK cell cytotoxicity by membrane raft depletion rather than inhibition of isoprenylation.

Authors:  Dianne Z Hillyard; Cian D Nutt; Jacqueline Thomson; Kenneth J McDonald; Ray K Wan; Angus J M Cameron; Patrick B Mark; Alan G Jardine
Journal:  Atherosclerosis       Date:  2006-06-30       Impact factor: 5.162

2.  Lipoproteins and CETP levels as risk factors for severe sepsis in hospitalized patients.

Authors:  Cintia M C Grion; Lucienne T Q Cardoso; Tatianna F Perazolo; Alexandre S Garcia; Décio S Barbosa; Helena Kaminami Morimoto; Tiemi Matsuo; Alexandre J F Carrilho
Journal:  Eur J Clin Invest       Date:  2010-04       Impact factor: 4.686

Review 3.  Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones.

Authors:  Anita H Payne; Dale B Hales
Journal:  Endocr Rev       Date:  2004-12       Impact factor: 19.871

4.  Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine.

Authors:  Paul E Marik; Stephen M Pastores; Djillali Annane; G Umberto Meduri; Charles L Sprung; Wiebke Arlt; Didier Keh; Josef Briegel; Albertus Beishuizen; Ioanna Dimopoulou; Stylianos Tsagarakis; Mervyn Singer; George P Chrousos; Gary Zaloga; Faran Bokhari; Michael Vogeser
Journal:  Crit Care Med       Date:  2008-06       Impact factor: 7.598

5.  Increased inflammatory markers with altered antioxidant status persist after clinical recovery from severe sepsis: a correlation with low HDL cholesterol and albumin.

Authors:  Lucie Vavrova; Jana Rychlikova; Magdalena Mrackova; Olga Novakova; Ales Zak; Frantisek Novak
Journal:  Clin Exp Med       Date:  2015-09-28       Impact factor: 3.984

6.  Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide.

Authors:  Ulf Diczfalusy; Katarina E Olofsson; Ann-Margreth Carlsson; Mei Gong; Douglas T Golenbock; Olav Rooyackers; Urban Fläring; Harry Björkbacka
Journal:  J Lipid Res       Date:  2009-06-05       Impact factor: 5.922

7.  Reconstituted high-density lipoprotein attenuates organ injury and adhesion molecule expression in a rodent model of endotoxic shock.

Authors:  Michelle C McDonald; Pal Dhadly; Gillian W Cockerill; Salvatore Cuzzocrea; Helder Mota-Filipe; Charles J Hinds; Norman E Miller; Christoph Thiemermann
Journal:  Shock       Date:  2003-12       Impact factor: 3.454

8.  Rosuvastatin for sepsis-associated acute respiratory distress syndrome.

Authors:  Jonathon D Truwit; Gordon R Bernard; Jay Steingrub; Michael A Matthay; Kathleen D Liu; Timothy E Albertson; Roy G Brower; Carl Shanholtz; Peter Rock; Ivor S Douglas; Bennett P deBoisblanc; Catherine L Hough; R Duncan Hite; B Taylor Thompson
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

9.  Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate.

Authors:  Nienke Molenaar; Ronald M Bijkerk; Albertus Beishuizen; Christel M Hempen; Margriet F C de Jong; Istvan Vermes; Gertjan van der Sluijs Veer; Armand R J Girbes; A B Johan Groeneveld
Journal:  Crit Care       Date:  2012-07-10       Impact factor: 9.097

10.  Circulating bile acids predict outcome in critically ill patients.

Authors:  Thomas Horvatits; Andreas Drolz; Karoline Rutter; Kevin Roedl; Lies Langouche; Greet Van den Berghe; Günter Fauler; Brigitte Meyer; Martin Hülsmann; Gottfried Heinz; Michael Trauner; Valentin Fuhrmann
Journal:  Ann Intensive Care       Date:  2017-05-02       Impact factor: 6.925

View more
  1 in total

Review 1.  The liver in sepsis: molecular mechanism of liver failure and their potential for clinical translation.

Authors:  Dustin Beyer; Jessica Hoff; Oliver Sommerfeld; Alexander Zipprich; Nikolaus Gaßler; Adrian T Press
Journal:  Mol Med       Date:  2022-07-30       Impact factor: 6.376

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.